Global Perphenazine Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global Perphenazine market size was valued at US$ 111 million in 2025 and is forecast to a readjusted size of US$ 138 million by 2032 with a CAGR of 3.2% during review period.
Perphenazine is a phenothiazine-class typical antipsychotic that mainly acts by blocking dopamine D2 receptors in the central nervous system. It is used to improve symptoms of schizophrenia and other psychotic disorders, including hallucinations, delusions, excitement, agitation, and disorganized thinking, and in certain clinical settings it is also used to control severe nausea, vomiting, or persistent hiccups. Perphenazine is commonly supplied as oral tablets, while other dosage forms may exist depending on market authorization and registration status. Compared with newer atypical antipsychotics, the core value of perphenazine does not lie in high-priced innovation, but in established efficacy, long clinical use history, affordability, primary-care accessibility, and its foundational role in long-term maintenance therapy. Its industry profile combines the characteristics of a mature chemical drug, a mental health public-service medicine, and a long-term chronic disease management product.In 2025, global Perphenazine Drug production reached approximately 15.6 million units.The average gross profit margin of this product is 35%.
The core opportunities in the perphenazine market come from the continued improvement of mental health service systems, the promotion of standardized management for severe mental disorders, enhanced primary care and community follow-up capabilities, and the foundational value of mature antipsychotics in long-term maintenance therapy. Continued government efforts to expand mental health service networks and improve access to psychological and psychiatric care give classic psychiatric medicines with stable supply, affordability, and controllable cost a continuing public health role. For companies, perphenazine is not a high-premium product driven by conceptual marketing; its commercial resilience comes from quality consistency, stable supply, hospital access, primary-care distribution, and physician prescribing trust. Against the backdrop of uneven psychiatric resource distribution and the need to support long-term medication adherence, perphenazine remains a foundational category with real-world demand and supply value within the mental health medication system.
The main challenges in the perphenazine industry are high product maturity, sufficient generic competition, and limited price elasticity, making it difficult for companies to achieve significant premiums through ordinary marketing. As a first-generation antipsychotic, perphenazine requires clinical attention to safety issues such as extrapyramidal symptoms, tardive dyskinesia, sedation, hypotension, anticholinergic effects, hepatic impact, drug interactions, and medication risks in elderly patients, meaning product promotion must be based on standardized prescribing, risk communication, and pharmacovigilance. With increasing use of atypical antipsychotics, long-acting injectables, and integrated psychiatric rehabilitation programs, perphenazine?s market space is more concentrated among patients who are cost-sensitive, clinically stable, have good prior response, or require strong primary-care accessibility. Companies lacking stable production, quality consistency, and compliance capability will face pressure from centralized procurement, substitution, and regulatory supervision.
Downstream demand is shifting from simple drug procurement toward stable supply and standardized medication use built around long-term management of severe mental disorders. Psychiatric hospitals, psychiatric departments of general hospitals, primary chronic disease management institutions, community mental health service networks, and reimbursement systems are important pillars supporting sustained demand for perphenazine. Clinicians increasingly focus on predictable efficacy, convenience of dose adjustment, adverse reaction monitoring, safety in combination therapy, and long-term medication accessibility; patients and families place greater emphasis on affordability, uninterrupted supply, stable symptom control, and follow-up convenience. In the future, perphenazine products with stable quality, affordable pricing, deeper channel penetration, robust pharmacovigilance, and physician trust will be better positioned to maintain market vitality in primary mental health services, long-term maintenance therapy, and public health-oriented medication supply.
This report is a detailed and comprehensive analysis for global Perphenazine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Perphenazine market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Perphenazine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Perphenazine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Perphenazine market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Perphenazine market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Perphenazine is a phenothiazine-class typical antipsychotic that mainly acts by blocking dopamine D2 receptors in the central nervous system. It is used to improve symptoms of schizophrenia and other psychotic disorders, including hallucinations, delusions, excitement, agitation, and disorganized thinking, and in certain clinical settings it is also used to control severe nausea, vomiting, or persistent hiccups. Perphenazine is commonly supplied as oral tablets, while other dosage forms may exist depending on market authorization and registration status. Compared with newer atypical antipsychotics, the core value of perphenazine does not lie in high-priced innovation, but in established efficacy, long clinical use history, affordability, primary-care accessibility, and its foundational role in long-term maintenance therapy. Its industry profile combines the characteristics of a mature chemical drug, a mental health public-service medicine, and a long-term chronic disease management product.In 2025, global Perphenazine Drug production reached approximately 15.6 million units.The average gross profit margin of this product is 35%.
The core opportunities in the perphenazine market come from the continued improvement of mental health service systems, the promotion of standardized management for severe mental disorders, enhanced primary care and community follow-up capabilities, and the foundational value of mature antipsychotics in long-term maintenance therapy. Continued government efforts to expand mental health service networks and improve access to psychological and psychiatric care give classic psychiatric medicines with stable supply, affordability, and controllable cost a continuing public health role. For companies, perphenazine is not a high-premium product driven by conceptual marketing; its commercial resilience comes from quality consistency, stable supply, hospital access, primary-care distribution, and physician prescribing trust. Against the backdrop of uneven psychiatric resource distribution and the need to support long-term medication adherence, perphenazine remains a foundational category with real-world demand and supply value within the mental health medication system.
The main challenges in the perphenazine industry are high product maturity, sufficient generic competition, and limited price elasticity, making it difficult for companies to achieve significant premiums through ordinary marketing. As a first-generation antipsychotic, perphenazine requires clinical attention to safety issues such as extrapyramidal symptoms, tardive dyskinesia, sedation, hypotension, anticholinergic effects, hepatic impact, drug interactions, and medication risks in elderly patients, meaning product promotion must be based on standardized prescribing, risk communication, and pharmacovigilance. With increasing use of atypical antipsychotics, long-acting injectables, and integrated psychiatric rehabilitation programs, perphenazine?s market space is more concentrated among patients who are cost-sensitive, clinically stable, have good prior response, or require strong primary-care accessibility. Companies lacking stable production, quality consistency, and compliance capability will face pressure from centralized procurement, substitution, and regulatory supervision.
Downstream demand is shifting from simple drug procurement toward stable supply and standardized medication use built around long-term management of severe mental disorders. Psychiatric hospitals, psychiatric departments of general hospitals, primary chronic disease management institutions, community mental health service networks, and reimbursement systems are important pillars supporting sustained demand for perphenazine. Clinicians increasingly focus on predictable efficacy, convenience of dose adjustment, adverse reaction monitoring, safety in combination therapy, and long-term medication accessibility; patients and families place greater emphasis on affordability, uninterrupted supply, stable symptom control, and follow-up convenience. In the future, perphenazine products with stable quality, affordable pricing, deeper channel penetration, robust pharmacovigilance, and physician trust will be better positioned to maintain market vitality in primary mental health services, long-term maintenance therapy, and public health-oriented medication supply.
This report is a detailed and comprehensive analysis for global Perphenazine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Perphenazine market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Perphenazine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Perphenazine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Perphenazine market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
- To determine the size of the total market opportunity of global and key countries
- To assess the growth potential for Perphenazine
- To forecast future growth in each product and end-use market
- To assess competitive factors affecting the marketplace
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Perphenazine market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Oral Forms
- Injectable Solution
- Schizophrenia
- Severe Nausea and Vomiting
- Other
- Psychiatric Hospital
- General Hospital Psychiatry
- Retail Pharmacy
- Psychosis
- Antiemetic
- Teva Pharmaceutical
- Sandoz
- Hikma Pharmaceuticals
- Amneal Pharmaceuticals
- Shanghai Sine Pharmaceutical
- Hunan Dongting Pharmaceutical
- Shanghai Zhaohui Pharmaceutical
- Endo International
- Mitsubishi Tanabe
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
- Chapter 1, to describe Perphenazine product scope, market overview, market estimation caveats and base year.
- Chapter 2, to profile the top manufacturers of Perphenazine, with price, sales quantity, revenue, and global market share of Perphenazine from 2021 to 2026.
- Chapter 3, the Perphenazine competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
- Chapter 4, the Perphenazine breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
- Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
- Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Perphenazine market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
- Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
- Chapter 13, the key raw materials and key suppliers, and industry chain of Perphenazine.
- Chapter 14 and 15, to describe Perphenazine sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Perphenazine Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 Oral Forms
1.3.3 Injectable Solution
1.4 Market Analysis by Psychiatric Indication
1.4.1 Overview: Global Perphenazine Consumption Value by Psychiatric Indication: 2021 Versus 2025 Versus 2032
1.4.2 Schizophrenia
1.4.3 Severe Nausea and Vomiting
1.4.4 Other
1.5 Market Analysis by Supply Type
1.5.1 Overview: Global Perphenazine Consumption Value by Supply Type: 2021 Versus 2025 Versus 2032
1.5.2 Psychiatric Hospital
1.5.3 General Hospital Psychiatry
1.5.4 Retail Pharmacy
1.6 Market Analysis by Application
1.6.1 Overview: Global Perphenazine Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.6.2 Psychosis
1.6.3 Antiemetic
1.7 Global Perphenazine Market Size & Forecast
1.7.1 Global Perphenazine Consumption Value (2021 & 2025 & 2032)
1.7.2 Global Perphenazine Sales Quantity (2021-2032)
1.7.3 Global Perphenazine Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 Teva Pharmaceutical
2.1.1 Teva Pharmaceutical Details
2.1.2 Teva Pharmaceutical Major Business
2.1.3 Teva Pharmaceutical Perphenazine Product and Services
2.1.4 Teva Pharmaceutical Perphenazine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Teva Pharmaceutical Recent Developments/Updates
2.2 Sandoz
2.2.1 Sandoz Details
2.2.2 Sandoz Major Business
2.2.3 Sandoz Perphenazine Product and Services
2.2.4 Sandoz Perphenazine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Sandoz Recent Developments/Updates
2.3 Hikma Pharmaceuticals
2.3.1 Hikma Pharmaceuticals Details
2.3.2 Hikma Pharmaceuticals Major Business
2.3.3 Hikma Pharmaceuticals Perphenazine Product and Services
2.3.4 Hikma Pharmaceuticals Perphenazine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Hikma Pharmaceuticals Recent Developments/Updates
2.4 Amneal Pharmaceuticals
2.4.1 Amneal Pharmaceuticals Details
2.4.2 Amneal Pharmaceuticals Major Business
2.4.3 Amneal Pharmaceuticals Perphenazine Product and Services
2.4.4 Amneal Pharmaceuticals Perphenazine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Amneal Pharmaceuticals Recent Developments/Updates
2.5 Shanghai Sine Pharmaceutical
2.5.1 Shanghai Sine Pharmaceutical Details
2.5.2 Shanghai Sine Pharmaceutical Major Business
2.5.3 Shanghai Sine Pharmaceutical Perphenazine Product and Services
2.5.4 Shanghai Sine Pharmaceutical Perphenazine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Shanghai Sine Pharmaceutical Recent Developments/Updates
2.6 Hunan Dongting Pharmaceutical
2.6.1 Hunan Dongting Pharmaceutical Details
2.6.2 Hunan Dongting Pharmaceutical Major Business
2.6.3 Hunan Dongting Pharmaceutical Perphenazine Product and Services
2.6.4 Hunan Dongting Pharmaceutical Perphenazine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Hunan Dongting Pharmaceutical Recent Developments/Updates
2.7 Shanghai Zhaohui Pharmaceutical
2.7.1 Shanghai Zhaohui Pharmaceutical Details
2.7.2 Shanghai Zhaohui Pharmaceutical Major Business
2.7.3 Shanghai Zhaohui Pharmaceutical Perphenazine Product and Services
2.7.4 Shanghai Zhaohui Pharmaceutical Perphenazine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Shanghai Zhaohui Pharmaceutical Recent Developments/Updates
2.8 Endo International
2.8.1 Endo International Details
2.8.2 Endo International Major Business
2.8.3 Endo International Perphenazine Product and Services
2.8.4 Endo International Perphenazine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Endo International Recent Developments/Updates
2.9 Mitsubishi Tanabe
2.9.1 Mitsubishi Tanabe Details
2.9.2 Mitsubishi Tanabe Major Business
2.9.3 Mitsubishi Tanabe Perphenazine Product and Services
2.9.4 Mitsubishi Tanabe Perphenazine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Mitsubishi Tanabe Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: PERPHENAZINE BY MANUFACTURER
3.1 Global Perphenazine Sales Quantity by Manufacturer (2021-2026)
3.2 Global Perphenazine Revenue by Manufacturer (2021-2026)
3.3 Global Perphenazine Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of Perphenazine by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 Perphenazine Manufacturer Market Share in 2025
3.4.3 Top 6 Perphenazine Manufacturer Market Share in 2025
3.5 Perphenazine Market: Overall Company Footprint Analysis
3.5.1 Perphenazine Market: Region Footprint
3.5.2 Perphenazine Market: Company Product Type Footprint
3.5.3 Perphenazine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Perphenazine Market Size by Region
4.1.1 Global Perphenazine Sales Quantity by Region (2021-2032)
4.1.2 Global Perphenazine Consumption Value by Region (2021-2032)
4.1.3 Global Perphenazine Average Price by Region (2021-2032)
4.2 North America Perphenazine Consumption Value (2021-2032)
4.3 Europe Perphenazine Consumption Value (2021-2032)
4.4 Asia-Pacific Perphenazine Consumption Value (2021-2032)
4.5 South America Perphenazine Consumption Value (2021-2032)
4.6 Middle East & Africa Perphenazine Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global Perphenazine Sales Quantity by Type (2021-2032)
5.2 Global Perphenazine Consumption Value by Type (2021-2032)
5.3 Global Perphenazine Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Perphenazine Sales Quantity by Application (2021-2032)
6.2 Global Perphenazine Consumption Value by Application (2021-2032)
6.3 Global Perphenazine Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America Perphenazine Sales Quantity by Type (2021-2032)
7.2 North America Perphenazine Sales Quantity by Application (2021-2032)
7.3 North America Perphenazine Market Size by Country
7.3.1 North America Perphenazine Sales Quantity by Country (2021-2032)
7.3.2 North America Perphenazine Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe Perphenazine Sales Quantity by Type (2021-2032)
8.2 Europe Perphenazine Sales Quantity by Application (2021-2032)
8.3 Europe Perphenazine Market Size by Country
8.3.1 Europe Perphenazine Sales Quantity by Country (2021-2032)
8.3.2 Europe Perphenazine Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific Perphenazine Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Perphenazine Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Perphenazine Market Size by Region
9.3.1 Asia-Pacific Perphenazine Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific Perphenazine Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America Perphenazine Sales Quantity by Type (2021-2032)
10.2 South America Perphenazine Sales Quantity by Application (2021-2032)
10.3 South America Perphenazine Market Size by Country
10.3.1 South America Perphenazine Sales Quantity by Country (2021-2032)
10.3.2 South America Perphenazine Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Perphenazine Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Perphenazine Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Perphenazine Market Size by Country
11.3.1 Middle East & Africa Perphenazine Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa Perphenazine Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 Perphenazine Market Drivers
12.2 Perphenazine Market Restraints
12.3 Perphenazine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Perphenazine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Perphenazine
13.3 Perphenazine Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Perphenazine Typical Distributors
14.3 Perphenazine Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Perphenazine Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 Oral Forms
1.3.3 Injectable Solution
1.4 Market Analysis by Psychiatric Indication
1.4.1 Overview: Global Perphenazine Consumption Value by Psychiatric Indication: 2021 Versus 2025 Versus 2032
1.4.2 Schizophrenia
1.4.3 Severe Nausea and Vomiting
1.4.4 Other
1.5 Market Analysis by Supply Type
1.5.1 Overview: Global Perphenazine Consumption Value by Supply Type: 2021 Versus 2025 Versus 2032
1.5.2 Psychiatric Hospital
1.5.3 General Hospital Psychiatry
1.5.4 Retail Pharmacy
1.6 Market Analysis by Application
1.6.1 Overview: Global Perphenazine Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.6.2 Psychosis
1.6.3 Antiemetic
1.7 Global Perphenazine Market Size & Forecast
1.7.1 Global Perphenazine Consumption Value (2021 & 2025 & 2032)
1.7.2 Global Perphenazine Sales Quantity (2021-2032)
1.7.3 Global Perphenazine Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 Teva Pharmaceutical
2.1.1 Teva Pharmaceutical Details
2.1.2 Teva Pharmaceutical Major Business
2.1.3 Teva Pharmaceutical Perphenazine Product and Services
2.1.4 Teva Pharmaceutical Perphenazine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Teva Pharmaceutical Recent Developments/Updates
2.2 Sandoz
2.2.1 Sandoz Details
2.2.2 Sandoz Major Business
2.2.3 Sandoz Perphenazine Product and Services
2.2.4 Sandoz Perphenazine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Sandoz Recent Developments/Updates
2.3 Hikma Pharmaceuticals
2.3.1 Hikma Pharmaceuticals Details
2.3.2 Hikma Pharmaceuticals Major Business
2.3.3 Hikma Pharmaceuticals Perphenazine Product and Services
2.3.4 Hikma Pharmaceuticals Perphenazine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Hikma Pharmaceuticals Recent Developments/Updates
2.4 Amneal Pharmaceuticals
2.4.1 Amneal Pharmaceuticals Details
2.4.2 Amneal Pharmaceuticals Major Business
2.4.3 Amneal Pharmaceuticals Perphenazine Product and Services
2.4.4 Amneal Pharmaceuticals Perphenazine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Amneal Pharmaceuticals Recent Developments/Updates
2.5 Shanghai Sine Pharmaceutical
2.5.1 Shanghai Sine Pharmaceutical Details
2.5.2 Shanghai Sine Pharmaceutical Major Business
2.5.3 Shanghai Sine Pharmaceutical Perphenazine Product and Services
2.5.4 Shanghai Sine Pharmaceutical Perphenazine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Shanghai Sine Pharmaceutical Recent Developments/Updates
2.6 Hunan Dongting Pharmaceutical
2.6.1 Hunan Dongting Pharmaceutical Details
2.6.2 Hunan Dongting Pharmaceutical Major Business
2.6.3 Hunan Dongting Pharmaceutical Perphenazine Product and Services
2.6.4 Hunan Dongting Pharmaceutical Perphenazine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Hunan Dongting Pharmaceutical Recent Developments/Updates
2.7 Shanghai Zhaohui Pharmaceutical
2.7.1 Shanghai Zhaohui Pharmaceutical Details
2.7.2 Shanghai Zhaohui Pharmaceutical Major Business
2.7.3 Shanghai Zhaohui Pharmaceutical Perphenazine Product and Services
2.7.4 Shanghai Zhaohui Pharmaceutical Perphenazine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Shanghai Zhaohui Pharmaceutical Recent Developments/Updates
2.8 Endo International
2.8.1 Endo International Details
2.8.2 Endo International Major Business
2.8.3 Endo International Perphenazine Product and Services
2.8.4 Endo International Perphenazine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Endo International Recent Developments/Updates
2.9 Mitsubishi Tanabe
2.9.1 Mitsubishi Tanabe Details
2.9.2 Mitsubishi Tanabe Major Business
2.9.3 Mitsubishi Tanabe Perphenazine Product and Services
2.9.4 Mitsubishi Tanabe Perphenazine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Mitsubishi Tanabe Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: PERPHENAZINE BY MANUFACTURER
3.1 Global Perphenazine Sales Quantity by Manufacturer (2021-2026)
3.2 Global Perphenazine Revenue by Manufacturer (2021-2026)
3.3 Global Perphenazine Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of Perphenazine by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 Perphenazine Manufacturer Market Share in 2025
3.4.3 Top 6 Perphenazine Manufacturer Market Share in 2025
3.5 Perphenazine Market: Overall Company Footprint Analysis
3.5.1 Perphenazine Market: Region Footprint
3.5.2 Perphenazine Market: Company Product Type Footprint
3.5.3 Perphenazine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Perphenazine Market Size by Region
4.1.1 Global Perphenazine Sales Quantity by Region (2021-2032)
4.1.2 Global Perphenazine Consumption Value by Region (2021-2032)
4.1.3 Global Perphenazine Average Price by Region (2021-2032)
4.2 North America Perphenazine Consumption Value (2021-2032)
4.3 Europe Perphenazine Consumption Value (2021-2032)
4.4 Asia-Pacific Perphenazine Consumption Value (2021-2032)
4.5 South America Perphenazine Consumption Value (2021-2032)
4.6 Middle East & Africa Perphenazine Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global Perphenazine Sales Quantity by Type (2021-2032)
5.2 Global Perphenazine Consumption Value by Type (2021-2032)
5.3 Global Perphenazine Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Perphenazine Sales Quantity by Application (2021-2032)
6.2 Global Perphenazine Consumption Value by Application (2021-2032)
6.3 Global Perphenazine Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America Perphenazine Sales Quantity by Type (2021-2032)
7.2 North America Perphenazine Sales Quantity by Application (2021-2032)
7.3 North America Perphenazine Market Size by Country
7.3.1 North America Perphenazine Sales Quantity by Country (2021-2032)
7.3.2 North America Perphenazine Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe Perphenazine Sales Quantity by Type (2021-2032)
8.2 Europe Perphenazine Sales Quantity by Application (2021-2032)
8.3 Europe Perphenazine Market Size by Country
8.3.1 Europe Perphenazine Sales Quantity by Country (2021-2032)
8.3.2 Europe Perphenazine Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific Perphenazine Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Perphenazine Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Perphenazine Market Size by Region
9.3.1 Asia-Pacific Perphenazine Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific Perphenazine Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America Perphenazine Sales Quantity by Type (2021-2032)
10.2 South America Perphenazine Sales Quantity by Application (2021-2032)
10.3 South America Perphenazine Market Size by Country
10.3.1 South America Perphenazine Sales Quantity by Country (2021-2032)
10.3.2 South America Perphenazine Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Perphenazine Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Perphenazine Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Perphenazine Market Size by Country
11.3.1 Middle East & Africa Perphenazine Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa Perphenazine Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 Perphenazine Market Drivers
12.2 Perphenazine Market Restraints
12.3 Perphenazine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Perphenazine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Perphenazine
13.3 Perphenazine Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Perphenazine Typical Distributors
14.3 Perphenazine Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Perphenazine Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Perphenazine Consumption Value by Psychiatric Indication, (USD Million), 2021 & 2025 & 2032
Table 3. Global Perphenazine Consumption Value by Supply Type, (USD Million), 2021 & 2025 & 2032
Table 4. Global Perphenazine Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 6. Teva Pharmaceutical Major Business
Table 7. Teva Pharmaceutical Perphenazine Product and Services
Table 8. Teva Pharmaceutical Perphenazine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 9. Teva Pharmaceutical Recent Developments/Updates
Table 10. Sandoz Basic Information, Manufacturing Base and Competitors
Table 11. Sandoz Major Business
Table 12. Sandoz Perphenazine Product and Services
Table 13. Sandoz Perphenazine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 14. Sandoz Recent Developments/Updates
Table 15. Hikma Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 16. Hikma Pharmaceuticals Major Business
Table 17. Hikma Pharmaceuticals Perphenazine Product and Services
Table 18. Hikma Pharmaceuticals Perphenazine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 19. Hikma Pharmaceuticals Recent Developments/Updates
Table 20. Amneal Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 21. Amneal Pharmaceuticals Major Business
Table 22. Amneal Pharmaceuticals Perphenazine Product and Services
Table 23. Amneal Pharmaceuticals Perphenazine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 24. Amneal Pharmaceuticals Recent Developments/Updates
Table 25. Shanghai Sine Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 26. Shanghai Sine Pharmaceutical Major Business
Table 27. Shanghai Sine Pharmaceutical Perphenazine Product and Services
Table 28. Shanghai Sine Pharmaceutical Perphenazine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 29. Shanghai Sine Pharmaceutical Recent Developments/Updates
Table 30. Hunan Dongting Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 31. Hunan Dongting Pharmaceutical Major Business
Table 32. Hunan Dongting Pharmaceutical Perphenazine Product and Services
Table 33. Hunan Dongting Pharmaceutical Perphenazine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 34. Hunan Dongting Pharmaceutical Recent Developments/Updates
Table 35. Shanghai Zhaohui Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 36. Shanghai Zhaohui Pharmaceutical Major Business
Table 37. Shanghai Zhaohui Pharmaceutical Perphenazine Product and Services
Table 38. Shanghai Zhaohui Pharmaceutical Perphenazine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 39. Shanghai Zhaohui Pharmaceutical Recent Developments/Updates
Table 40. Endo International Basic Information, Manufacturing Base and Competitors
Table 41. Endo International Major Business
Table 42. Endo International Perphenazine Product and Services
Table 43. Endo International Perphenazine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 44. Endo International Recent Developments/Updates
Table 45. Mitsubishi Tanabe Basic Information, Manufacturing Base and Competitors
Table 46. Mitsubishi Tanabe Major Business
Table 47. Mitsubishi Tanabe Perphenazine Product and Services
Table 48. Mitsubishi Tanabe Perphenazine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 49. Mitsubishi Tanabe Recent Developments/Updates
Table 50. Global Perphenazine Sales Quantity by Manufacturer (2021-2026) & (K Units)
Table 51. Global Perphenazine Revenue by Manufacturer (2021-2026) & (USD Million)
Table 52. Global Perphenazine Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 53. Market Position of Manufacturers in Perphenazine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 54. Head Office and Perphenazine Production Site of Key Manufacturer
Table 55. Perphenazine Market: Company Product Type Footprint
Table 56. Perphenazine Market: Company Product Application Footprint
Table 57. Perphenazine New Market Entrants and Barriers to Market Entry
Table 58. Perphenazine Mergers, Acquisition, Agreements, and Collaborations
Table 59. Global Perphenazine Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 60. Global Perphenazine Sales Quantity by Region (2021-2026) & (K Units)
Table 61. Global Perphenazine Sales Quantity by Region (2027-2032) & (K Units)
Table 62. Global Perphenazine Consumption Value by Region (2021-2026) & (USD Million)
Table 63. Global Perphenazine Consumption Value by Region (2027-2032) & (USD Million)
Table 64. Global Perphenazine Average Price by Region (2021-2026) & (US$/Unit)
Table 65. Global Perphenazine Average Price by Region (2027-2032) & (US$/Unit)
Table 66. Global Perphenazine Sales Quantity by Type (2021-2026) & (K Units)
Table 67. Global Perphenazine Sales Quantity by Type (2027-2032) & (K Units)
Table 68. Global Perphenazine Consumption Value by Type (2021-2026) & (USD Million)
Table 69. Global Perphenazine Consumption Value by Type (2027-2032) & (USD Million)
Table 70. Global Perphenazine Average Price by Type (2021-2026) & (US$/Unit)
Table 71. Global Perphenazine Average Price by Type (2027-2032) & (US$/Unit)
Table 72. Global Perphenazine Sales Quantity by Application (2021-2026) & (K Units)
Table 73. Global Perphenazine Sales Quantity by Application (2027-2032) & (K Units)
Table 74. Global Perphenazine Consumption Value by Application (2021-2026) & (USD Million)
Table 75. Global Perphenazine Consumption Value by Application (2027-2032) & (USD Million)
Table 76. Global Perphenazine Average Price by Application (2021-2026) & (US$/Unit)
Table 77. Global Perphenazine Average Price by Application (2027-2032) & (US$/Unit)
Table 78. North America Perphenazine Sales Quantity by Type (2021-2026) & (K Units)
Table 79. North America Perphenazine Sales Quantity by Type (2027-2032) & (K Units)
Table 80. North America Perphenazine Sales Quantity by Application (2021-2026) & (K Units)
Table 81. North America Perphenazine Sales Quantity by Application (2027-2032) & (K Units)
Table 82. North America Perphenazine Sales Quantity by Country (2021-2026) & (K Units)
Table 83. North America Perphenazine Sales Quantity by Country (2027-2032) & (K Units)
Table 84. North America Perphenazine Consumption Value by Country (2021-2026) & (USD Million)
Table 85. North America Perphenazine Consumption Value by Country (2027-2032) & (USD Million)
Table 86. Europe Perphenazine Sales Quantity by Type (2021-2026) & (K Units)
Table 87. Europe Perphenazine Sales Quantity by Type (2027-2032) & (K Units)
Table 88. Europe Perphenazine Sales Quantity by Application (2021-2026) & (K Units)
Table 89. Europe Perphenazine Sales Quantity by Application (2027-2032) & (K Units)
Table 90. Europe Perphenazine Sales Quantity by Country (2021-2026) & (K Units)
Table 91. Europe Perphenazine Sales Quantity by Country (2027-2032) & (K Units)
Table 92. Europe Perphenazine Consumption Value by Country (2021-2026) & (USD Million)
Table 93. Europe Perphenazine Consumption Value by Country (2027-2032) & (USD Million)
Table 94. Asia-Pacific Perphenazine Sales Quantity by Type (2021-2026) & (K Units)
Table 95. Asia-Pacific Perphenazine Sales Quantity by Type (2027-2032) & (K Units)
Table 96. Asia-Pacific Perphenazine Sales Quantity by Application (2021-2026) & (K Units)
Table 97. Asia-Pacific Perphenazine Sales Quantity by Application (2027-2032) & (K Units)
Table 98. Asia-Pacific Perphenazine Sales Quantity by Region (2021-2026) & (K Units)
Table 99. Asia-Pacific Perphenazine Sales Quantity by Region (2027-2032) & (K Units)
Table 100. Asia-Pacific Perphenazine Consumption Value by Region (2021-2026) & (USD Million)
Table 101. Asia-Pacific Perphenazine Consumption Value by Region (2027-2032) & (USD Million)
Table 102. South America Perphenazine Sales Quantity by Type (2021-2026) & (K Units)
Table 103. South America Perphenazine Sales Quantity by Type (2027-2032) & (K Units)
Table 104. South America Perphenazine Sales Quantity by Application (2021-2026) & (K Units)
Table 105. South America Perphenazine Sales Quantity by Application (2027-2032) & (K Units)
Table 106. South America Perphenazine Sales Quantity by Country (2021-2026) & (K Units)
Table 107. South America Perphenazine Sales Quantity by Country (2027-2032) & (K Units)
Table 108. South America Perphenazine Consumption Value by Country (2021-2026) & (USD Million)
Table 109. South America Perphenazine Consumption Value by Country (2027-2032) & (USD Million)
Table 110. Middle East & Africa Perphenazine Sales Quantity by Type (2021-2026) & (K Units)
Table 111. Middle East & Africa Perphenazine Sales Quantity by Type (2027-2032) & (K Units)
Table 112. Middle East & Africa Perphenazine Sales Quantity by Application (2021-2026) & (K Units)
Table 113. Middle East & Africa Perphenazine Sales Quantity by Application (2027-2032) & (K Units)
Table 114. Middle East & Africa Perphenazine Sales Quantity by Country (2021-2026) & (K Units)
Table 115. Middle East & Africa Perphenazine Sales Quantity by Country (2027-2032) & (K Units)
Table 116. Middle East & Africa Perphenazine Consumption Value by Country (2021-2026) & (USD Million)
Table 117. Middle East & Africa Perphenazine Consumption Value by Country (2027-2032) & (USD Million)
Table 118. Perphenazine Raw Material
Table 119. Key Manufacturers of Perphenazine Raw Materials
Table 120. Perphenazine Typical Distributors
Table 121. Perphenazine Typical Customers
Table 1. Global Perphenazine Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Perphenazine Consumption Value by Psychiatric Indication, (USD Million), 2021 & 2025 & 2032
Table 3. Global Perphenazine Consumption Value by Supply Type, (USD Million), 2021 & 2025 & 2032
Table 4. Global Perphenazine Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 6. Teva Pharmaceutical Major Business
Table 7. Teva Pharmaceutical Perphenazine Product and Services
Table 8. Teva Pharmaceutical Perphenazine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 9. Teva Pharmaceutical Recent Developments/Updates
Table 10. Sandoz Basic Information, Manufacturing Base and Competitors
Table 11. Sandoz Major Business
Table 12. Sandoz Perphenazine Product and Services
Table 13. Sandoz Perphenazine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 14. Sandoz Recent Developments/Updates
Table 15. Hikma Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 16. Hikma Pharmaceuticals Major Business
Table 17. Hikma Pharmaceuticals Perphenazine Product and Services
Table 18. Hikma Pharmaceuticals Perphenazine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 19. Hikma Pharmaceuticals Recent Developments/Updates
Table 20. Amneal Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 21. Amneal Pharmaceuticals Major Business
Table 22. Amneal Pharmaceuticals Perphenazine Product and Services
Table 23. Amneal Pharmaceuticals Perphenazine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 24. Amneal Pharmaceuticals Recent Developments/Updates
Table 25. Shanghai Sine Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 26. Shanghai Sine Pharmaceutical Major Business
Table 27. Shanghai Sine Pharmaceutical Perphenazine Product and Services
Table 28. Shanghai Sine Pharmaceutical Perphenazine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 29. Shanghai Sine Pharmaceutical Recent Developments/Updates
Table 30. Hunan Dongting Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 31. Hunan Dongting Pharmaceutical Major Business
Table 32. Hunan Dongting Pharmaceutical Perphenazine Product and Services
Table 33. Hunan Dongting Pharmaceutical Perphenazine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 34. Hunan Dongting Pharmaceutical Recent Developments/Updates
Table 35. Shanghai Zhaohui Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 36. Shanghai Zhaohui Pharmaceutical Major Business
Table 37. Shanghai Zhaohui Pharmaceutical Perphenazine Product and Services
Table 38. Shanghai Zhaohui Pharmaceutical Perphenazine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 39. Shanghai Zhaohui Pharmaceutical Recent Developments/Updates
Table 40. Endo International Basic Information, Manufacturing Base and Competitors
Table 41. Endo International Major Business
Table 42. Endo International Perphenazine Product and Services
Table 43. Endo International Perphenazine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 44. Endo International Recent Developments/Updates
Table 45. Mitsubishi Tanabe Basic Information, Manufacturing Base and Competitors
Table 46. Mitsubishi Tanabe Major Business
Table 47. Mitsubishi Tanabe Perphenazine Product and Services
Table 48. Mitsubishi Tanabe Perphenazine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 49. Mitsubishi Tanabe Recent Developments/Updates
Table 50. Global Perphenazine Sales Quantity by Manufacturer (2021-2026) & (K Units)
Table 51. Global Perphenazine Revenue by Manufacturer (2021-2026) & (USD Million)
Table 52. Global Perphenazine Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 53. Market Position of Manufacturers in Perphenazine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 54. Head Office and Perphenazine Production Site of Key Manufacturer
Table 55. Perphenazine Market: Company Product Type Footprint
Table 56. Perphenazine Market: Company Product Application Footprint
Table 57. Perphenazine New Market Entrants and Barriers to Market Entry
Table 58. Perphenazine Mergers, Acquisition, Agreements, and Collaborations
Table 59. Global Perphenazine Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 60. Global Perphenazine Sales Quantity by Region (2021-2026) & (K Units)
Table 61. Global Perphenazine Sales Quantity by Region (2027-2032) & (K Units)
Table 62. Global Perphenazine Consumption Value by Region (2021-2026) & (USD Million)
Table 63. Global Perphenazine Consumption Value by Region (2027-2032) & (USD Million)
Table 64. Global Perphenazine Average Price by Region (2021-2026) & (US$/Unit)
Table 65. Global Perphenazine Average Price by Region (2027-2032) & (US$/Unit)
Table 66. Global Perphenazine Sales Quantity by Type (2021-2026) & (K Units)
Table 67. Global Perphenazine Sales Quantity by Type (2027-2032) & (K Units)
Table 68. Global Perphenazine Consumption Value by Type (2021-2026) & (USD Million)
Table 69. Global Perphenazine Consumption Value by Type (2027-2032) & (USD Million)
Table 70. Global Perphenazine Average Price by Type (2021-2026) & (US$/Unit)
Table 71. Global Perphenazine Average Price by Type (2027-2032) & (US$/Unit)
Table 72. Global Perphenazine Sales Quantity by Application (2021-2026) & (K Units)
Table 73. Global Perphenazine Sales Quantity by Application (2027-2032) & (K Units)
Table 74. Global Perphenazine Consumption Value by Application (2021-2026) & (USD Million)
Table 75. Global Perphenazine Consumption Value by Application (2027-2032) & (USD Million)
Table 76. Global Perphenazine Average Price by Application (2021-2026) & (US$/Unit)
Table 77. Global Perphenazine Average Price by Application (2027-2032) & (US$/Unit)
Table 78. North America Perphenazine Sales Quantity by Type (2021-2026) & (K Units)
Table 79. North America Perphenazine Sales Quantity by Type (2027-2032) & (K Units)
Table 80. North America Perphenazine Sales Quantity by Application (2021-2026) & (K Units)
Table 81. North America Perphenazine Sales Quantity by Application (2027-2032) & (K Units)
Table 82. North America Perphenazine Sales Quantity by Country (2021-2026) & (K Units)
Table 83. North America Perphenazine Sales Quantity by Country (2027-2032) & (K Units)
Table 84. North America Perphenazine Consumption Value by Country (2021-2026) & (USD Million)
Table 85. North America Perphenazine Consumption Value by Country (2027-2032) & (USD Million)
Table 86. Europe Perphenazine Sales Quantity by Type (2021-2026) & (K Units)
Table 87. Europe Perphenazine Sales Quantity by Type (2027-2032) & (K Units)
Table 88. Europe Perphenazine Sales Quantity by Application (2021-2026) & (K Units)
Table 89. Europe Perphenazine Sales Quantity by Application (2027-2032) & (K Units)
Table 90. Europe Perphenazine Sales Quantity by Country (2021-2026) & (K Units)
Table 91. Europe Perphenazine Sales Quantity by Country (2027-2032) & (K Units)
Table 92. Europe Perphenazine Consumption Value by Country (2021-2026) & (USD Million)
Table 93. Europe Perphenazine Consumption Value by Country (2027-2032) & (USD Million)
Table 94. Asia-Pacific Perphenazine Sales Quantity by Type (2021-2026) & (K Units)
Table 95. Asia-Pacific Perphenazine Sales Quantity by Type (2027-2032) & (K Units)
Table 96. Asia-Pacific Perphenazine Sales Quantity by Application (2021-2026) & (K Units)
Table 97. Asia-Pacific Perphenazine Sales Quantity by Application (2027-2032) & (K Units)
Table 98. Asia-Pacific Perphenazine Sales Quantity by Region (2021-2026) & (K Units)
Table 99. Asia-Pacific Perphenazine Sales Quantity by Region (2027-2032) & (K Units)
Table 100. Asia-Pacific Perphenazine Consumption Value by Region (2021-2026) & (USD Million)
Table 101. Asia-Pacific Perphenazine Consumption Value by Region (2027-2032) & (USD Million)
Table 102. South America Perphenazine Sales Quantity by Type (2021-2026) & (K Units)
Table 103. South America Perphenazine Sales Quantity by Type (2027-2032) & (K Units)
Table 104. South America Perphenazine Sales Quantity by Application (2021-2026) & (K Units)
Table 105. South America Perphenazine Sales Quantity by Application (2027-2032) & (K Units)
Table 106. South America Perphenazine Sales Quantity by Country (2021-2026) & (K Units)
Table 107. South America Perphenazine Sales Quantity by Country (2027-2032) & (K Units)
Table 108. South America Perphenazine Consumption Value by Country (2021-2026) & (USD Million)
Table 109. South America Perphenazine Consumption Value by Country (2027-2032) & (USD Million)
Table 110. Middle East & Africa Perphenazine Sales Quantity by Type (2021-2026) & (K Units)
Table 111. Middle East & Africa Perphenazine Sales Quantity by Type (2027-2032) & (K Units)
Table 112. Middle East & Africa Perphenazine Sales Quantity by Application (2021-2026) & (K Units)
Table 113. Middle East & Africa Perphenazine Sales Quantity by Application (2027-2032) & (K Units)
Table 114. Middle East & Africa Perphenazine Sales Quantity by Country (2021-2026) & (K Units)
Table 115. Middle East & Africa Perphenazine Sales Quantity by Country (2027-2032) & (K Units)
Table 116. Middle East & Africa Perphenazine Consumption Value by Country (2021-2026) & (USD Million)
Table 117. Middle East & Africa Perphenazine Consumption Value by Country (2027-2032) & (USD Million)
Table 118. Perphenazine Raw Material
Table 119. Key Manufacturers of Perphenazine Raw Materials
Table 120. Perphenazine Typical Distributors
Table 121. Perphenazine Typical Customers
LIST OF FIGURES
Figure 1. Perphenazine Picture
Figure 2. Global Perphenazine Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Perphenazine Revenue Market Share by Type in 2025
Figure 4. Oral Forms Examples
Figure 5. Injectable Solution Examples
Figure 6. Global Perphenazine Revenue by Psychiatric Indication, (USD Million), 2021 & 2025 & 2032
Figure 7. Global Perphenazine Revenue Market Share by Psychiatric Indication in 2025
Figure 8. Schizophrenia Examples
Figure 9. Severe Nausea and Vomiting Examples
Figure 10. Other Examples
Figure 11. Global Perphenazine Revenue by Supply Type, (USD Million), 2021 & 2025 & 2032
Figure 12. Global Perphenazine Revenue Market Share by Supply Type in 2025
Figure 13. Psychiatric Hospital Examples
Figure 14. General Hospital Psychiatry Examples
Figure 15. Retail Pharmacy Examples
Figure 16. Global Perphenazine Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 17. Global Perphenazine Revenue Market Share by Application in 2025
Figure 18. Psychosis Examples
Figure 19. Antiemetic Examples
Figure 20. Global Perphenazine Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 21. Global Perphenazine Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 22. Global Perphenazine Sales Quantity (2021-2032) & (K Units)
Figure 23. Global Perphenazine Price (2021-2032) & (US$/Unit)
Figure 24. Global Perphenazine Sales Quantity Market Share by Manufacturer in 2025
Figure 25. Global Perphenazine Revenue Market Share by Manufacturer in 2025
Figure 26. Producer Shipments of Perphenazine by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 27. Top 3 Perphenazine Manufacturer (Revenue) Market Share in 2025
Figure 28. Top 6 Perphenazine Manufacturer (Revenue) Market Share in 2025
Figure 29. Global Perphenazine Sales Quantity Market Share by Region (2021-2032)
Figure 30. Global Perphenazine Consumption Value Market Share by Region (2021-2032)
Figure 31. North America Perphenazine Consumption Value (2021-2032) & (USD Million)
Figure 32. Europe Perphenazine Consumption Value (2021-2032) & (USD Million)
Figure 33. Asia-Pacific Perphenazine Consumption Value (2021-2032) & (USD Million)
Figure 34. South America Perphenazine Consumption Value (2021-2032) & (USD Million)
Figure 35. Middle East & Africa Perphenazine Consumption Value (2021-2032) & (USD Million)
Figure 36. Global Perphenazine Sales Quantity Market Share by Type (2021-2032)
Figure 37. Global Perphenazine Consumption Value Market Share by Type (2021-2032)
Figure 38. Global Perphenazine Average Price by Type (2021-2032) & (US$/Unit)
Figure 39. Global Perphenazine Sales Quantity Market Share by Application (2021-2032)
Figure 40. Global Perphenazine Revenue Market Share by Application (2021-2032)
Figure 41. Global Perphenazine Average Price by Application (2021-2032) & (US$/Unit)
Figure 42. North America Perphenazine Sales Quantity Market Share by Type (2021-2032)
Figure 43. North America Perphenazine Sales Quantity Market Share by Application (2021-2032)
Figure 44. North America Perphenazine Sales Quantity Market Share by Country (2021-2032)
Figure 45. North America Perphenazine Consumption Value Market Share by Country (2021-2032)
Figure 46. United States Perphenazine Consumption Value (2021-2032) & (USD Million)
Figure 47. Canada Perphenazine Consumption Value (2021-2032) & (USD Million)
Figure 48. Mexico Perphenazine Consumption Value (2021-2032) & (USD Million)
Figure 49. Europe Perphenazine Sales Quantity Market Share by Type (2021-2032)
Figure 50. Europe Perphenazine Sales Quantity Market Share by Application (2021-2032)
Figure 51. Europe Perphenazine Sales Quantity Market Share by Country (2021-2032)
Figure 52. Europe Perphenazine Consumption Value Market Share by Country (2021-2032)
Figure 53. Germany Perphenazine Consumption Value (2021-2032) & (USD Million)
Figure 54. France Perphenazine Consumption Value (2021-2032) & (USD Million)
Figure 55. United Kingdom Perphenazine Consumption Value (2021-2032) & (USD Million)
Figure 56. Russia Perphenazine Consumption Value (2021-2032) & (USD Million)
Figure 57. Italy Perphenazine Consumption Value (2021-2032) & (USD Million)
Figure 58. Asia-Pacific Perphenazine Sales Quantity Market Share by Type (2021-2032)
Figure 59. Asia-Pacific Perphenazine Sales Quantity Market Share by Application (2021-2032)
Figure 60. Asia-Pacific Perphenazine Sales Quantity Market Share by Region (2021-2032)
Figure 61. Asia-Pacific Perphenazine Consumption Value Market Share by Region (2021-2032)
Figure 62. China Perphenazine Consumption Value (2021-2032) & (USD Million)
Figure 63. Japan Perphenazine Consumption Value (2021-2032) & (USD Million)
Figure 64. South Korea Perphenazine Consumption Value (2021-2032) & (USD Million)
Figure 65. India Perphenazine Consumption Value (2021-2032) & (USD Million)
Figure 66. Southeast Asia Perphenazine Consumption Value (2021-2032) & (USD Million)
Figure 67. Australia Perphenazine Consumption Value (2021-2032) & (USD Million)
Figure 68. South America Perphenazine Sales Quantity Market Share by Type (2021-2032)
Figure 69. South America Perphenazine Sales Quantity Market Share by Application (2021-2032)
Figure 70. South America Perphenazine Sales Quantity Market Share by Country (2021-2032)
Figure 71. South America Perphenazine Consumption Value Market Share by Country (2021-2032)
Figure 72. Brazil Perphenazine Consumption Value (2021-2032) & (USD Million)
Figure 73. Argentina Perphenazine Consumption Value (2021-2032) & (USD Million)
Figure 74. Middle East & Africa Perphenazine Sales Quantity Market Share by Type (2021-2032)
Figure 75. Middle East & Africa Perphenazine Sales Quantity Market Share by Application (2021-2032)
Figure 76. Middle East & Africa Perphenazine Sales Quantity Market Share by Country (2021-2032)
Figure 77. Middle East & Africa Perphenazine Consumption Value Market Share by Country (2021-2032)
Figure 78. Turkey Perphenazine Consumption Value (2021-2032) & (USD Million)
Figure 79. Egypt Perphenazine Consumption Value (2021-2032) & (USD Million)
Figure 80. Saudi Arabia Perphenazine Consumption Value (2021-2032) & (USD Million)
Figure 81. South Africa Perphenazine Consumption Value (2021-2032) & (USD Million)
Figure 82. Perphenazine Market Drivers
Figure 83. Perphenazine Market Restraints
Figure 84. Perphenazine Market Trends
Figure 85. Porters Five Forces Analysis
Figure 86. Manufacturing Cost Structure Analysis of Perphenazine in 2025
Figure 87. Manufacturing Process Analysis of Perphenazine
Figure 88. Perphenazine Industrial Chain
Figure 89. Sales Channel: Direct to End-User vs Distributors
Figure 90. Direct Channel Pros & Cons
Figure 91. Indirect Channel Pros & Cons
Figure 92. Methodology
Figure 93. Research Process and Data Source
Figure 1. Perphenazine Picture
Figure 2. Global Perphenazine Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Perphenazine Revenue Market Share by Type in 2025
Figure 4. Oral Forms Examples
Figure 5. Injectable Solution Examples
Figure 6. Global Perphenazine Revenue by Psychiatric Indication, (USD Million), 2021 & 2025 & 2032
Figure 7. Global Perphenazine Revenue Market Share by Psychiatric Indication in 2025
Figure 8. Schizophrenia Examples
Figure 9. Severe Nausea and Vomiting Examples
Figure 10. Other Examples
Figure 11. Global Perphenazine Revenue by Supply Type, (USD Million), 2021 & 2025 & 2032
Figure 12. Global Perphenazine Revenue Market Share by Supply Type in 2025
Figure 13. Psychiatric Hospital Examples
Figure 14. General Hospital Psychiatry Examples
Figure 15. Retail Pharmacy Examples
Figure 16. Global Perphenazine Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 17. Global Perphenazine Revenue Market Share by Application in 2025
Figure 18. Psychosis Examples
Figure 19. Antiemetic Examples
Figure 20. Global Perphenazine Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 21. Global Perphenazine Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 22. Global Perphenazine Sales Quantity (2021-2032) & (K Units)
Figure 23. Global Perphenazine Price (2021-2032) & (US$/Unit)
Figure 24. Global Perphenazine Sales Quantity Market Share by Manufacturer in 2025
Figure 25. Global Perphenazine Revenue Market Share by Manufacturer in 2025
Figure 26. Producer Shipments of Perphenazine by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 27. Top 3 Perphenazine Manufacturer (Revenue) Market Share in 2025
Figure 28. Top 6 Perphenazine Manufacturer (Revenue) Market Share in 2025
Figure 29. Global Perphenazine Sales Quantity Market Share by Region (2021-2032)
Figure 30. Global Perphenazine Consumption Value Market Share by Region (2021-2032)
Figure 31. North America Perphenazine Consumption Value (2021-2032) & (USD Million)
Figure 32. Europe Perphenazine Consumption Value (2021-2032) & (USD Million)
Figure 33. Asia-Pacific Perphenazine Consumption Value (2021-2032) & (USD Million)
Figure 34. South America Perphenazine Consumption Value (2021-2032) & (USD Million)
Figure 35. Middle East & Africa Perphenazine Consumption Value (2021-2032) & (USD Million)
Figure 36. Global Perphenazine Sales Quantity Market Share by Type (2021-2032)
Figure 37. Global Perphenazine Consumption Value Market Share by Type (2021-2032)
Figure 38. Global Perphenazine Average Price by Type (2021-2032) & (US$/Unit)
Figure 39. Global Perphenazine Sales Quantity Market Share by Application (2021-2032)
Figure 40. Global Perphenazine Revenue Market Share by Application (2021-2032)
Figure 41. Global Perphenazine Average Price by Application (2021-2032) & (US$/Unit)
Figure 42. North America Perphenazine Sales Quantity Market Share by Type (2021-2032)
Figure 43. North America Perphenazine Sales Quantity Market Share by Application (2021-2032)
Figure 44. North America Perphenazine Sales Quantity Market Share by Country (2021-2032)
Figure 45. North America Perphenazine Consumption Value Market Share by Country (2021-2032)
Figure 46. United States Perphenazine Consumption Value (2021-2032) & (USD Million)
Figure 47. Canada Perphenazine Consumption Value (2021-2032) & (USD Million)
Figure 48. Mexico Perphenazine Consumption Value (2021-2032) & (USD Million)
Figure 49. Europe Perphenazine Sales Quantity Market Share by Type (2021-2032)
Figure 50. Europe Perphenazine Sales Quantity Market Share by Application (2021-2032)
Figure 51. Europe Perphenazine Sales Quantity Market Share by Country (2021-2032)
Figure 52. Europe Perphenazine Consumption Value Market Share by Country (2021-2032)
Figure 53. Germany Perphenazine Consumption Value (2021-2032) & (USD Million)
Figure 54. France Perphenazine Consumption Value (2021-2032) & (USD Million)
Figure 55. United Kingdom Perphenazine Consumption Value (2021-2032) & (USD Million)
Figure 56. Russia Perphenazine Consumption Value (2021-2032) & (USD Million)
Figure 57. Italy Perphenazine Consumption Value (2021-2032) & (USD Million)
Figure 58. Asia-Pacific Perphenazine Sales Quantity Market Share by Type (2021-2032)
Figure 59. Asia-Pacific Perphenazine Sales Quantity Market Share by Application (2021-2032)
Figure 60. Asia-Pacific Perphenazine Sales Quantity Market Share by Region (2021-2032)
Figure 61. Asia-Pacific Perphenazine Consumption Value Market Share by Region (2021-2032)
Figure 62. China Perphenazine Consumption Value (2021-2032) & (USD Million)
Figure 63. Japan Perphenazine Consumption Value (2021-2032) & (USD Million)
Figure 64. South Korea Perphenazine Consumption Value (2021-2032) & (USD Million)
Figure 65. India Perphenazine Consumption Value (2021-2032) & (USD Million)
Figure 66. Southeast Asia Perphenazine Consumption Value (2021-2032) & (USD Million)
Figure 67. Australia Perphenazine Consumption Value (2021-2032) & (USD Million)
Figure 68. South America Perphenazine Sales Quantity Market Share by Type (2021-2032)
Figure 69. South America Perphenazine Sales Quantity Market Share by Application (2021-2032)
Figure 70. South America Perphenazine Sales Quantity Market Share by Country (2021-2032)
Figure 71. South America Perphenazine Consumption Value Market Share by Country (2021-2032)
Figure 72. Brazil Perphenazine Consumption Value (2021-2032) & (USD Million)
Figure 73. Argentina Perphenazine Consumption Value (2021-2032) & (USD Million)
Figure 74. Middle East & Africa Perphenazine Sales Quantity Market Share by Type (2021-2032)
Figure 75. Middle East & Africa Perphenazine Sales Quantity Market Share by Application (2021-2032)
Figure 76. Middle East & Africa Perphenazine Sales Quantity Market Share by Country (2021-2032)
Figure 77. Middle East & Africa Perphenazine Consumption Value Market Share by Country (2021-2032)
Figure 78. Turkey Perphenazine Consumption Value (2021-2032) & (USD Million)
Figure 79. Egypt Perphenazine Consumption Value (2021-2032) & (USD Million)
Figure 80. Saudi Arabia Perphenazine Consumption Value (2021-2032) & (USD Million)
Figure 81. South Africa Perphenazine Consumption Value (2021-2032) & (USD Million)
Figure 82. Perphenazine Market Drivers
Figure 83. Perphenazine Market Restraints
Figure 84. Perphenazine Market Trends
Figure 85. Porters Five Forces Analysis
Figure 86. Manufacturing Cost Structure Analysis of Perphenazine in 2025
Figure 87. Manufacturing Process Analysis of Perphenazine
Figure 88. Perphenazine Industrial Chain
Figure 89. Sales Channel: Direct to End-User vs Distributors
Figure 90. Direct Channel Pros & Cons
Figure 91. Indirect Channel Pros & Cons
Figure 92. Methodology
Figure 93. Research Process and Data Source
